Five Progress Party MPs propose strengthening Norway's pharmaceutical preparedness through domestic production. The proposers argue that Norway is almost entirely dependent on imported medicines, leaving the country vulnerable during crises, and that a 2021 Storting resolution on emergency supply agreements has gone unimplemented. They ask the government to establish a national preparedness model, negotiate agreements with Norwegian producers, and secure funding for essential raw materials.
AI-generated summary · Model: Claude Haiku 4.5 · Generated: 14 May 2026
These are the proposals in the document, not decisions. See the votes for the outcome.
The Storting calls on the government to establish a national preparedness model for Norwegian production of critical medicines, including painkillers, anesthetics, and antibiotics, as well as other medicines needed during crises.
The Storting calls on the government to negotiate within six months with relevant Norwegian pharmaceutical producers and conclude emergency supply agreements that secure access to production capacity in crisis and conflict.
The Storting calls on the government to ensure the state finances necessary raw materials and packaging, so production can be mobilized on short notice without delays linked to imports.
The Storting calls on the government to present an updated and concrete pharmaceutical preparedness plan in which Norwegian production capacity figures as a central component.
The Storting calls on the government to enter advance purchase agreements to drive private investment in establishing Norwegian vaccine production.
The Storting calls on the government to report annually to the Storting on the status of Norwegian pharmaceutical production as part of overall preparedness, including agreements concluded and progress made.